The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
The treat-all policy will only succeed if people keep taking their HIV treatment. It is important to motivate people who started treatment while they were still feeling well.
Epidemics of HIV and HPV are inherently interconnected – and when they meet in the context of weak health systems, their effects are amplifed.
Untreated depression could seriously compromise treatment outcomes for people living with HIV, warn critics.
Expanding access to treatment for people living with HIV is shown to decrease tuberculosis (TB) incidence – but it is not the silver bullet.
Study in South Africa and Burkina Faso shows that simple HPV screening could help save lives in places with limited health infrastructure.
Kenya becomes first country in the world to introduce child-friendly tuberculosis (TB) medicine. It is hoped that the roll-out of this medication will drastically reduce the number of child TB deaths in the country.
Sitting in her small flat that she once shared with friends in Zimbabwe's capital Harare, Hope* (27), a sex worker chronicles life from her first diagnosis with tuberculosis (TB) and later HIV.
AVERT has launched a new partnership to support communities affected by the dual epidemics of HIV and tuberculosis (TB) in Zambia, thanks to funding from Comic Relief.
The recent Ebola outbreak in Sierra Leon has disrupted HIV care in the country, with hospitals closed because they are overrun with Ebola patients, and non-Ebola patients are too afraid to visit hospitals in fear of getting the virus. The United Nations Development Programme (UNDP) has raised concerns, believing this may lead to an increase in HIV prevalence and antiretroviral drug resistance.
Treating pregnant HIV-positive women who are on antiretroviral treatment (ART) for helminth infections, also known as worm infections, is proven to increase CD4 count and haemoglobin level and decrease viral HIV load. These findings are a result of a recently published study in Clinical Infectious Diseases, conducted in Rwanda.